A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

Recruiting

Phase 1

GDC-6988A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

Sponsor:

Genentech, Inc.

Code:

NCT06603246

Conditions

Non-cystic Fibrosis Bronchiectasis

Chronic Obstructive Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

GDC-6988

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-13. This information was provided to ClinicalTrials.gov by Genentech, Inc. on 2026-08-04.